Evidence map›Paper›PMID 40813872›Full record

ArticleScientific reports2025

Enhanced activity localization and microscale dosimetry in alpha-emitter radiopharmaceutical therapy using integrated autoradiography and histological imaging.

Sandeep Sahota, Krystal A Quirindongo, Joseph Piccolo, Anupriya Chhabra, Nouran Zaid, Simin Deveauxbray, Kenechukwu C Charles-Obi, Brian Miller, Robert F Hobbs, George Sgouros and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sandeep SahotaMallinckrodt Institute of Radiology, University of Washington in St. Louis School of Medicine, St. Louis, MO, USA.
Krystal A QuirindongoMallinckrodt Institute of Radiology, University of Washington in St. Louis School of Medicine, St. Louis, MO, USA.
Joseph PiccoloRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Anupriya ChhabraRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nouran ZaidRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Simin DeveauxbrayRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kenechukwu C Charles-ObiRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Brian MillerDepartment of Radiation Oncology, Department of Medical Imaging, College of Medicine, University of Arizona, Tucson, AZ, USA.
Robert F HobbsRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
George SgourosRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Remco BastiaannetMallinckrodt Institute of Radiology, University of Washington in St. Louis School of Medicine, St. Louis, MO, USA. remco@wustl.edu.ORCID http://orcid.org/0000-0001-7056-3229

Funding

Radiobioeffect Modeling of αRPTP01CA272222 · NCI · JOHNS HOPKINS UNIVERSITY · PI Ana Ponce Kiess · 2023 to 2026
$12.8M
NIH NCI P01CA272222Society of Nuclear Medicine and Molecular Imaging 2023 SNMMI Molecular Imaging Research Grant for Junior Academic Faculty
6 · The paper itself

Abstract

Alpha-emitter radiopharmaceutical therapy delivers highly localized radiation, offering potent therapeutic effects. However, microscale heterogeneity remains poorly characterized in vivo and may affect efficacy. This underscores the critical need for sub-organ dosimetry to better understand αRPT radiobiology and guide treatment optimization. While autoradiography enables high-resolution activity mapping, conventional approaches lack anatomical context for accurate dose mapping. To address this, we propose a comprehensive workflow integrating quantitative autoradiography with histological imaging. Tissues from αRPT-treated mice bearing HER2 + breast tumors were snap-frozen, sectioned, and imaged using autoradiography. The same sections were histologically stained and used for precise autoradiography-histology integration. These anatomical contexts were then used to accurately stack multiple sections in a 3D volume, and were used for subsequent microscale dosimetry. Both tumor and kidney tissues were analyzed. Snap-freezing in isopentane preserved tissue morphology optimally. Our method enabled precise activity localization, revealing significant accumulation in the kidney cortex region close to glomeruli. Anatomical context improved 3D reconstructions needed for accurate dose estimations in tumor tissue. This methodology enhances αRPT dosimetry by precise spatial mapping of autoradiography unto the underlying tissue morphology. These advancements provide crucial insights into αRPT spatial radiobiology at the near-cellular level and will aid in optimizing radiopharmaceutical design and treatment planning.

Indexed as

Alpha ParticlesAutoradiographyBreast NeoplasmsRadiopharmaceuticalsAnimalsCell Line, TumorFemaleHumansKidneyMiceRadiometryRadiopharmaceuticals

Identifiers

PMID40813872
PMCPMC12354851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.